Loading stock…

The Pennant Group, Inc. (PNTG) Stock Verdict & Ratings | Investment Bastion

Stock Verdict·Updated 1d ago

The Pennant Group, Inc.

PNTGMarket cap $1.40BPrice $40.0

Country🇺🇸United States

SectorHealthcare

IndustryHealthcare Services

Operates home health, hospice, and senior living services across the U.S., spun off from Ensign Group in 2019. Bets on America's aging population, serving patients who'd rather heal at home than in a hospital bed.

In Bastion Portfolios?

52W Return+69%Global Market +16%?

01Key Ratings

How does this stock score across Bastion factors?

Growth

Historical Revenue

Rev CAGR (3y)+26%9

Revenue Forecast

Rev CAGR (1y)+25%9

Rev CAGR (3y)+13%8

Rev CAGR (5y)+5%4

Earnings Forecast

EPS Growth Y+1+71%10

EPS Growth Y+2+17%8

EPS Growth Y+3+14%7

Quality

Margins

EBIT Margin6%3

Net Income Margin3%3

Free Cash Flow Margin2%3

Debt

Net Debt/EBITDA3.52

Efficiency

ROE10%4

ROA4%6

Earnings Stability77

GEAR+AVERAGE41

Overall rating across all five factors

Value

Price Multiples

P/E Ratio (Forward)253

P/E Ratio (Forward 3y)203

P/BV3.94

EV Multiples

EV/EBITDA Fwd202

EV/EBIT Fwd214

Yield

Free Cash Flow Yield1.9%4

Dividend Yieldna–

Momentum

Short term

1 month return+5%9

3 month return+1%7

YTD return+42%9

Mid term

Price vs 52wHigh93%9

1 year return+60%9

Long term

3 year return+252%9

5 year return+57%6

Risk Shield

Price Risk

Beta0.67

Volatility38%5

Free Cash Flow

Free Cash Flow Margin2%3

Free Cash Flow Yield1.9%4

Quality

ROCE8%5

Earnings Stability77

Net Debt/EBITDA3.52

02Growth

Is it actually growing, and how fast?

PNTGThe Pennant Group

Revenue FY25$948M

GROWTH RATING↗

STRONG72 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+26%9

Revenue, next 1Y+25%9

Revenue, next 3Y, CAGR+13%8

Revenue, next 5Y, CAGR+5%4

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+71%10

EPS growth, FY27E+17%8

EPS growth, FY28E+14%7

GROWTH ASSESSMENT

STRENGTHS

It out-grows 72% of companies worldwide.

Revenue grew 26%/yr over the last 3 years, ahead of 80% of companies worldwide.9/10

Revenue is set to grow 13%/yr over the next 3 years, ahead of most of the market.7/10

Earnings are set to grow in step with sales (EPS about 17%/yr vs revenue 13%/yr).

WATCH

Revenue grew 26%/yr over the last 3 years; forecasts see it cooling to 13%/yr.

Over five years revenue is set to grow 5%/yr, behind 60% of companies worldwide.4/10

WEAKNESSES

None flagged.

BOTTOM LINE

Elite Compounder

A top-tier grower that is slowing. The one thing to watch: the pace is cooling.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

VERY STRONG89 / 100

SHORT-TERM RETURNS▾SCORE

1-month return+5%9

3-month return+1%7

YTD return+42%9

MID & LONG-TERM▾SCORE

% of 52-week high93%9

1-year return+60%9

3-year return+252%9

5-year return+57%6

MOMENTUM ASSESSMENT

STRENGTHS

Strong long-term results. Long-term holders have seen +252% over three years and +57% over five, ahead of 70% of the market.

It's up 60% over the past year, now 7% below its 52-week high. That is clearly ahead of the market.

Strong recent results. The stock is outperforming over the past month (+5%), over three months (+1%) and so far this year (+42%).

WATCH

None flagged.

WEAKNESSES

None flagged.

BOTTOM LINE

Momentum Leader

Short- and long-term returns both rank among the best globally, and the stock trades near its highs. The market is fully behind it — a core fit for momentum strategies.

04Value

Are you paying a fair price for it?

Stop guessing on The Pennant Group, Inc.. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

PNTGThe Pennant Group

Revenue FY25$948M

GROWTH RATING↗

STRONG72 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+26%9

Revenue, next 1Y+25%9

Revenue, next 3Y, CAGR+13%8

Revenue, next 5Y, CAGR+5%4

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+71%10

EPS growth, FY27E+17%8

EPS growth, FY28E+14%7

GROWTH ASSESSMENT

STRENGTHS

It out-grows 72% of companies worldwide.

Revenue grew 26%/yr over the last 3 years, ahead of 80% of companies worldwide.9/10

Revenue is set to grow 13%/yr over the next 3 years, ahead of most of the market.7/10

Earnings are set to grow in step with sales (EPS about 17%/yr vs revenue 13%/yr).

WATCH

Revenue grew 26%/yr over the last 3 years; forecasts see it cooling to 13%/yr.

Over five years revenue is set to grow 5%/yr, behind 60% of companies worldwide.4/10

WEAKNESSES

None flagged.

BOTTOM LINE

Elite Compounder

A top-tier grower that is slowing. The one thing to watch: the pace is cooling.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

VERY STRONG89 / 100

SHORT-TERM RETURNS▾SCORE

1-month return+5%9

3-month return+1%7

YTD return+42%9

MID & LONG-TERM▾SCORE

% of 52-week high93%9

1-year return+60%9

3-year return+252%9

5-year return+57%6

MOMENTUM ASSESSMENT

STRENGTHS

Strong long-term results. Long-term holders have seen +252% over three years and +57% over five, ahead of 70% of the market.

It's up 60% over the past year, now 7% below its 52-week high. That is clearly ahead of the market.

Strong recent results. The stock is outperforming over the past month (+5%), over three months (+1%) and so far this year (+42%).

WATCH

None flagged.

WEAKNESSES

None flagged.

BOTTOM LINE

Momentum Leader

Short- and long-term returns both rank among the best globally, and the stock trades near its highs. The market is fully behind it — a core fit for momentum strategies.

04Value

Are you paying a fair price for it?

Stop guessing on The Pennant Group, Inc.. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community